High Rates of Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection in People Who Inject Drugs: A Prospective Cohort Study
Hepatitis C virus reinfection and spontaneous clearance of reinfection were examined in a highly characterisedcohort of 188 people who inject drugs over a five-year period. Nine confirmed reinfections and 17 possiblereinfections were identified (confirmed reinfections were those genetically distinct...
| Main Authors: | Sacks-Davis, R., Aitken, C., Higgs, Peter, Spelman, T., Pedrana, A., Bowden, S., Bharadwaj, M., Nivarthi, U., Suppiah, V., George, J., Grebely, J., Drummer, H., Hellard, M. |
|---|---|
| Format: | Journal Article |
| Published: |
Public Library of Science
2013
|
| Online Access: | http://hdl.handle.net/20.500.11937/49575 |
Similar Items
The effects of needle-sharing and opioid substitution therapy on incidence of hepatitis C virus infection and reinfection in people who inject drugs
by: Aitken, C., et al.
Published: (2017)
by: Aitken, C., et al.
Published: (2017)
Does informing people who inject drugs of their hepatitis C status influence their injecting behavior? Analysis of the Networks II study
by: Aspinall, E., et al.
Published: (2014)
by: Aspinall, E., et al.
Published: (2014)
Proportion and factors associated with covid-19 reinfection among Universiti Sains Malaysia health campus residents
by: Basri, Ijlal Syamim Mohd
Published: (2023)
by: Basri, Ijlal Syamim Mohd
Published: (2023)
Barriers to receiving hepatitis c treatment for people who inject drugs myths and evidence
by: Higgs, Peter, et al.
Published: (2011)
by: Higgs, Peter, et al.
Published: (2011)
Hepatitis C Virus Phylogenetic Clustering Is Associated with the Social-Injecting Network in a Cohort of People Who Inject Drugs
by: Sacks-Davis, R., et al.
Published: (2012)
by: Sacks-Davis, R., et al.
Published: (2012)
How “Hidden” Are Unobserved Networks Among People Who Inject Drugs?
by: Higgs, Peter, et al.
Published: (2015)
by: Higgs, Peter, et al.
Published: (2015)
The impact of injecting networks on hepatitis C transmission and treatment in people who inject drugs
by: Hellard, M., et al.
Published: (2014)
by: Hellard, M., et al.
Published: (2014)
Detection of HCV-specific IFN-gamma responses in HCV antibody and HCV RNA negative injecting drug users
by: Flynn, J., et al.
Published: (2014)
by: Flynn, J., et al.
Published: (2014)
Modelling antiviral treatment to prevent hepatitis C infection among people who inject drugs in Victoria, Australia
by: Hellard, M., et al.
Published: (2012)
by: Hellard, M., et al.
Published: (2012)
Hepatitis C transmission and treatment as prevention - The role of the injecting network
by: Hellard, M., et al.
Published: (2015)
by: Hellard, M., et al.
Published: (2015)
Preventing hepatitis C virus transmission among young people in the justice system
by: Lenton, E., et al.
Published: (2013)
by: Lenton, E., et al.
Published: (2013)
Experiences of liver health related uncertainty and self-reported stress among people who inject drugs living with hepatitis C virus: A qualitative study
by: Goutzamanis, S., et al.
Published: (2018)
by: Goutzamanis, S., et al.
Published: (2018)
Concordance between self-reported and actual hepatitis C virus infection status in a cohort of people who inject drugs
by: O’Keefe, D., et al.
Published: (2013)
by: O’Keefe, D., et al.
Published: (2013)
Is handedness associated with health outcomes for people who inject illicit drugs?
by: Aitken, C., et al.
Published: (2009)
by: Aitken, C., et al.
Published: (2009)
A yeast model for studying intracellular clearance of beta-amyloid 42
by: Bharadwaj, Prashant, et al.
Published: (2012)
by: Bharadwaj, Prashant, et al.
Published: (2012)
Improving hepatitis C direct-acting antiviral access and uptake: A role for patient-reported outcomes and lived experience
by: Goutzamanis, S., et al.
Published: (2019)
by: Goutzamanis, S., et al.
Published: (2019)
Effects of latrepirdine on Aß clearance, neurotoxicity and aggregation
by: Martins, R., et al.
Published: (2010)
by: Martins, R., et al.
Published: (2010)
Spontaneous resolution of asymptomatic hepatic pseudoaneurysm post radiofrequency ablation
by: Li, Shyan Ch'ng, et al.
Published: (2015)
by: Li, Shyan Ch'ng, et al.
Published: (2015)
Field engagement further facilitates hepatitis B vaccination completion: Letter in response to: Day et al. (in press)
by: Higgs, Peter, et al.
Published: (2016)
by: Higgs, Peter, et al.
Published: (2016)
Decreased IP-10 and elevated TGFß1 levels are associated with viral clearance following therapy in patients with hepatitis C virus
by: Lee, S., et al.
Published: (2010)
by: Lee, S., et al.
Published: (2010)
No Drama: Key Elements to the Success of an HIV/STI-Prevention Mass-Media Campaign
by: Pedrana, A., et al.
Published: (2014)
by: Pedrana, A., et al.
Published: (2014)
Under-keel clearance
by: Gourlay, Tim
Published: (2015)
by: Gourlay, Tim
Published: (2015)
A response to: Self-reported and actual hepatitis C virus status
by: O'Keefe, D., et al.
Published: (2014)
by: O'Keefe, D., et al.
Published: (2014)
Prediction of Car Ground Clearance
by: Zamri, Mohamed, et al.
Published: (2009)
by: Zamri, Mohamed, et al.
Published: (2009)
Understanding decisions made about hepatitis C treatment by couples who inject drugs.
by: Treloar, C., et al.
Published: (2015)
by: Treloar, C., et al.
Published: (2015)
Pharmacy-led hepatitis C treatment pathways to help ensure elimination
by: Gunn, J., et al.
Published: (2019)
by: Gunn, J., et al.
Published: (2019)
Harm reduction workers and the challenge of engaging couples who inject drugs in hepatitis C prevention.
by: Treloar, C., et al.
Published: (2016)
by: Treloar, C., et al.
Published: (2016)
Muscles affecting minimum toe clearance
by: Kenneth Perera, Chamalka, et al.
Published: (2021)
by: Kenneth Perera, Chamalka, et al.
Published: (2021)
“I'm obviously not dying so it's not something I need to sort out today”: Considering hepatitis C treatment in the era of direct acting antivirals
by: Wright, C., et al.
Published: (2018)
by: Wright, C., et al.
Published: (2018)
Acceptability and HIV Prevention Benefits of a Peer-Based Model of Rapid Point of Care HIV Testing for Australian Gay, Bisexual and Other Men Who Have Sex with Men
by: Leitinger, D., et al.
Published: (2018)
by: Leitinger, D., et al.
Published: (2018)
A cross-sectional study of emergency department visits by people who inject drugs
by: Aitken, C., et al.
Published: (2013)
by: Aitken, C., et al.
Published: (2013)
Longitudinal changes in personal wellbeing in a cohort of people who inject drugs
by: Scott, N., et al.
Published: (2017)
by: Scott, N., et al.
Published: (2017)
Pharmacies dispensing opioid substitution therapy also play a role in hepatitis C virus elimination
by: Gunn, J., et al.
Published: (2018)
by: Gunn, J., et al.
Published: (2018)
Socioeconomic consequences of the COVID‐19 pandemic for people who use drugs
by: Walker, Shelley, et al.
Published: (2023)
by: Walker, Shelley, et al.
Published: (2023)
Variation in clearance and invasiveness of pharmacokinetic studies in children
by: Altamimi, Mohammed Ibrahim
Published: (2016)
by: Altamimi, Mohammed Ibrahim
Published: (2016)
Hepatitis C and the limits of medicalisation and biological citizenship for people who inject drugs
by: Fraser, Suzanne
Published: (2010)
by: Fraser, Suzanne
Published: (2010)
Rapid testing for hepatitis C does not infer current infection
by: Nguyen, V., et al.
Published: (2017)
by: Nguyen, V., et al.
Published: (2017)
Chlamydia trachomatis and the risk of spontaneous preterm birth, babies who are born small for gestational age, and stillbirth: a population-based cohort study
by: Reekie, J., et al.
Published: (2018)
by: Reekie, J., et al.
Published: (2018)
‘Affording’ new approaches to couples who inject drugs: A novel fitpack design for hepatitis C prevention
by: Fraser, Suzanne, et al.
Published: (2017)
by: Fraser, Suzanne, et al.
Published: (2017)
Longitudinal changes in psychological distress in a cohort of people who inject drugs in Melbourne, Australia.
by: Scott, N., et al.
Published: (2016)
by: Scott, N., et al.
Published: (2016)
Similar Items
-
The effects of needle-sharing and opioid substitution therapy on incidence of hepatitis C virus infection and reinfection in people who inject drugs
by: Aitken, C., et al.
Published: (2017) -
Does informing people who inject drugs of their hepatitis C status influence their injecting behavior? Analysis of the Networks II study
by: Aspinall, E., et al.
Published: (2014) -
Proportion and factors associated with covid-19 reinfection among Universiti Sains Malaysia health campus residents
by: Basri, Ijlal Syamim Mohd
Published: (2023) -
Barriers to receiving hepatitis c treatment for people who inject drugs myths and evidence
by: Higgs, Peter, et al.
Published: (2011) -
Hepatitis C Virus Phylogenetic Clustering Is Associated with the Social-Injecting Network in a Cohort of People Who Inject Drugs
by: Sacks-Davis, R., et al.
Published: (2012)